Related Experiment Video
Updated: Nov 19, 2025

10:16
Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
Published on: August 17, 2022
3.6K
COVID-19 Vaccine Development to Vaccination
Ashok Pandey1, Pradeep Belbase1, Ayuska Parajuli2
1Nepal Health Research Council, Ramshah Path Kathmandu, Nepal.
Journal of Nepal Health Research Council
|January 29, 2021
Summary
Manufacturers are key to developing safe and effective Coronavirus disease-19 vaccines. Proper logistics, storage, and administration are crucial for vaccine efficacy and successful mass vaccination efforts.
Area of Science:
- Immunology
- Vaccinology
- Public Health
Background:
- The development of safe and effective Coronavirus disease-19 vaccines is a global priority.
- Manufacturers play a pivotal role across all stages of vaccine production and distribution.
- Understanding the factors influencing vaccine efficacy and public acceptance is essential.
Purpose of the Study:
- To highlight the critical role of manufacturers in Coronavirus disease-19 vaccine development and deployment.
- To emphasize the importance of logistical and administrative factors for vaccine efficacy and immune response.
- To underscore the need for improved health promotion and reduced vaccination barriers.
Main Methods:
- Review of manufacturer responsibilities in vaccine development, clinical trials, manufacturing, and supply chains.
- Analysis of factors influencing Coronavirus disease-19 vaccine efficacy, including transport, storage, and administration.
- Examination of logistical challenges and public willingness to pay for vaccines.
Main Results:
- Manufacturer involvement is critical from vaccine conception through to public administration.
- Optimal transport, storage, and administration methods are vital for achieving a robust immune response.
- Addressing logistical hurdles and enhancing health promotion are necessary for successful mass vaccination.
Conclusions:
- Effective Coronavirus disease-19 vaccination campaigns depend heavily on manufacturer performance and robust logistical frameworks.
- Improving vaccine delivery systems and public engagement strategies is paramount for controlling the pandemic.
- Continued research into vaccine development and administration is essential.
Related Concept Videos
Vaccinations
49.2K
Overview
49.2K
Cancer Vaccines
626
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
626
Development of Immunocompetence
584
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
584
Preclinical Development: Overview
5.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.5K
Microorganisms in Medicine and Therapeutics
668
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
668
Clinical Trials: Overview
4.3K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.3K

